Plan-year MSK savings delivered with a 3.2x ROI

Independent analysis shows that organizations using Sword AI Care see meaningful reductions in MSK and related medical spend.

Third-party validation is key to earning trust — and this independent analysis of Sword’s impact delivers exactly that.

Risk Strategies Consulting conducted a rigorous 18-month retrospective cohort study, comparing more than 2,700 Sword members to over 5,100 matched controls. The result: Sword drives substantial reductions in MSK and chronic-condition-related costs, even when controlling for region, comorbidities, and engagement thresholds.

This report confirms what leading employers and health plans already know — Sword works, and the numbers prove it.

Download the full validation report to see how Sword delivers medical savings across MSK and inactivity-related conditions, backed by robust claims analysis.